r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

PL

PERCEPTIVE ADVISORS LLC

Insider · Director · IMTX

PERCEPTIVE ADVISORS LLC files insider transactions with the SEC as a director of Immatics (IMTX). We hold 1 disclosed purchase or sale filed since 5 January 2007, 1 of them in the last 90 days.

  • Files forIMTX
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure27 August 2026

Positions held

20 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 16 June 2026 — 26 August 2026Director · Immatics (IMTX)2 Form 4 lines · source: SEC Form 4
  • Filed 20 July 2026 — 20 July 202610% owner · Freenome (FRNM)1 Form 4 line · source: SEC Form 4
  • Filed 9 April 2026 — 23 June 2026Director and 10% owner · LeonaBio (LONA)2 Form 4 lines · source: SEC Form 4
  • Filed 17 June 2026 — 17 June 2026Director · Kardigan (KARD)1 Form 4 line · source: SEC Form 4
  • Filed 19 June 2019 — 11 June 2026Director and 10% owner · MeiraGTx Holdings (MGTX)14 Form 4 lines · source: SEC Form 4
  • Filed 30 January 2018 — 10 June 2026Director and 10% owner · Solid Biosciences (SLDB)7 Form 4 lines · source: SEC Form 4
  • Filed 23 December 2025 — 23 December 2025Director and 10% owner · Athira Pharma (ATHA)9 Form 4 lines · source: SEC Form 4
  • Filed 30 April 2020 — 13 November 202510% owner · Lyra Therapeutics (LYRA)21 Form 4 lines · source: SEC Form 4
  • Filed 25 April 2025 — 1 May 202510% owner · Acrivon Therapeutics (ACRV)5 Form 4 lines · source: SEC Form 4
  • Filed 22 January 2025 — 22 January 2025Director and 10% owner · Adagio Medical Holdings (ADGM)1 Form 4 line · source: SEC Form 4
  • Filed 15 June 2022 — 14 June 2024Director and 10% owner · Nautilus Biotechnology (NAUT)2 Form 4 lines · source: SEC Form 4
  • Filed 23 August 2021 — 20 February 2024Director · Cerevel Therapeutics Holdings (CERE)4 Form 4 lines · source: SEC Form 4
  • Filed 19 June 2018 — 26 December 202310% owner · Verrica Pharmaceuticals (VRCA)11 Form 4 lines · source: SEC Form 4
  • Filed 21 December 2023 — 21 December 2023Director · Astria Therapeutics (ATXS)1 Form 4 line · source: SEC Form 4
  • Filed 19 May 2023 — 28 September 202310% owner · Soleno Therapeutics (SLNO)22 Form 4 lines · source: SEC Form 4
  • Filed 23 June 2022 — 21 June 2023Director and 10% owner · LianBio (LIAN)4 Form 4 lines · source: SEC Form 4
  • Filed 4 April 2023 — 6 April 202310% owner · Chembio Diagnostics (CEMI)3 Form 4 lines · source: SEC Form 4
  • Filed 6 December 2016 — 6 April 202310% owner · VBI Vaccines Inc/BC (VBIV)17 Form 4 lines · source: SEC Form 4
  • Filed 7 December 2018 — 31 October 202210% owner · Quotient (QTNT)2 Form 4 lines · source: SEC Form 4
  • Filed 14 September 2020 — 13 October 202210% owner · Albireo Pharma (ALBO)8 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.